跳至主要内容
临床试验/NCT05363865
NCT05363865已完成不适用

Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 511 人开始时间: 2023年6月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
511
试验地点
2
主要终点
Test HIV

研究概览

简要总结

The study is a cluster randomized controlled trial developed in counties located in Appalachia and the Midwest. We will prioritize counties from states with high risk for HIV and HCV infection associated with injection drug use.

详细描述

The study will randomize clusters with groups of participants to an intervention or a standard of care condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

The outcomes assessor will be unaware of the experimental condition.

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Lives in target zip codes
  • •Half not using illicit substances (not including marijuana) currently or in the past
  • •Half using illicit substances (not including marijuana) currently or in the past

排除标准

  • •Under the age of 18
  • •Not in target zip codes

研究组 & 干预措施

Virtual Community Intervention

Experimental

Participants will participate in an online community with structured sessions as well as the ability to communicate freely with others.

干预措施: Virtual Community Intervention (Behavioral)

Standard of Care

Active Comparator

Participants will be exposed to what's disseminated within their communities

干预措施: Standard of Care (Behavioral)

结局指标

主要结局

Test HIV

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-request of HIV test and confirmation of completion. Binary (Yes/No)

Test HCV

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-request of HCV test and confirmation of completion. Binary (Yes/No)

Know HIV Status

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of HIV status understanding. Binary (I tested positive for HIV; I tested negative for HIV.)

Know HCV Status

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of HCV status understanding. Binary (I tested positive for HCV; I tested negative for HCV.)

Receive HIV Treatment

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of HIV treatment reception. Binary (Yes/No)

Receive HCV Treatment

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of HCV treatment reception. Binary (Yes/No)

Receive Over-the-Counter Narcan

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Request to receive over-the-counter Narcan, depending on the ability to distribute Narcan in the state of residence. Binary (Yes/No)

Use syringe services (e.g., exchange)

时间窗: Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of using a syringe service program. Binary (Yes/No)

Disinfect injection equipment

时间窗: Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of injection tool cleaning prior to use. Binary (Yes/No)

New Social Connections

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of new social connections made with others in the community. Continuous (Numeric)

Renewed Social Connections

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of reconnecting with previously distant community members. Continuous (Numeric)

Contributions to town, neighborhoods, and community

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of community engagement and betterment through acts of service or kindness. Scale (Not at all; A little; Somewhat; A lot; A great deal)

Discovering services or groups

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of newly discovered social services or groups in their communities. Binary (Yes/No)

Joining groups, organizations, or activities

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of newly joined groups, organizations, or activities in the community. Binary (Yes/No)

Encouraging others to test for HIV/HCV

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of instances where individuals suggest or encourage HIV/HCV testing. Binary (Yes/No)

Encouraging others to treat substance use disorder or HIV/HCV

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of instances where individuals suggest or encourage others to be treated for substance use disorder, HIV, or HCV. Binary (Yes/No)

Discuss substance use issues with others

时间窗: Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months

Self-report of instances where individual discusses substance use issues with other members of their community. Binary (Yes/No)

次要结局

  • Use PrEP(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Use a condom during sex(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Support for another with a health issue(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Support somebody who is presently struggling with substance use disorder(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Support somebody who has had struggles with substance use disorder(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Support somebody who has a family member who has a substance use disorder(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Refrain from using hurtful language to refer to people with substance use disorder(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Refrain from using hurtful language to refer to people from other groups (e.g., religious)(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Intention to intervene when someone uses hurtful language(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • See a mental health professional if there are mental health concerns including substance use(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Attend a 12-step group (if using substances or in recovery)(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Attend another abstinence-based program (if using substances or in recovery)(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Attend a substance use treatment program that uses medications (if using substances or in recovery)(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Attend a religious-based substance use group (if using substances or in recovery)(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Receive COVID-19 vaccine(s) as currently required (measure past and last shot)(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Take a flu shot during the most recent season(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Carry Naloxone(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Use Naloxone on someone(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Has someone administered Naloxone on you?(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Test for COVID-19(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Test for M-pox(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Drink alcohol frequency(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Use substance without a prescription or more than prescribed(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Injection drug use(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Use someone else's syringe(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Complete Narcan training(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Requesting safe-injection supplies(Baseline, Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Support for medication assisted treatment (MAT)(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)
  • Support for therapeutic programs to reduce drug addiction(Baseline, Session 2 (~2 weeks, Experimental Group Only), Session 3 (~3 weeks, Experimental Group Only), Immediate Follow-Up (3 Weeks), 3 months, 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验